Wells Fargo
ANVS icon

Wells Fargo’s Annovis Bio ANVS Stock Holding History

Wells Fargo’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.9K Hold
14,307
– – ﹤0.01% 5602
2025
Q4 		$49.5K Buy
14,307
+4,561
+47% +$13.7K ﹤0.01% 5583
2025
Q3 		$20.2K Hold
9,746
– – ﹤0.01% 5800
2025
Q2 		$21.1K Hold
9,746
– – ﹤0.01% 5776
2025
Q1 		$14.6K Hold
9,746
– – ﹤0.01% 5792
2024
Q4 		$49K Hold
9,746
– – ﹤0.01% 5491
2024
Q3 		$78.6K Buy
9,746
+999
+11% +$9.36K ﹤0.01% 5151
2024
Q2 		$50.4K Sell
8,747
-54
-0.6% -$438 ﹤0.01% 5288
2024
Q1 		$105K Buy
8,801
+1
+0% +$11 ﹤0.01% 4866
2023
Q4 		$165K Buy
8,800
+9
+0.1% +$80 ﹤0.01% 4586
2023
Q3 		$83.4K Buy
8,791
+1
+0% +$12 ﹤0.01% 4887
2023
Q2 		$126K Buy
8,790
+6
+0.1% +$85 ﹤0.01% 4893
2023
Q1 		$135K Buy
8,784
+1
+0% +$16 ﹤0.01% 4661
2022
Q4 		$118K Buy
8,783
+1
+0% +$13 ﹤0.01% 4456
2022
Q3 		$121K Buy
8,782
+1
+0% +$13 ﹤0.01% 4508
2022
Q2 		$99K Buy
8,781
+4
+0% +$44 ﹤0.01% 4642
2022
Q1 		$117K Hold
8,777
– – ﹤0.01% 5239
2021
Q4 		$155K Sell
8,777
-1,000
-10% -$25.8K ﹤0.01% 5408
2021
Q3 		$310K Buy
9,777
+9,240
+1,721% +$531K ﹤0.01% 4909
2021
Q2 		$47K Buy
537
+512
+2,048% +$23.7K ﹤0.01% 5585
2021
Q1 		$1K Buy
25
+2
+9% +$43 ﹤0.01% 6681
2020
Q4 		$0 Hold
23
– – ﹤0.01% 6460
2020
Q3 		$0 Buy
+23
New +$123 ﹤0.01% 6302

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Wells Fargo's ANVS Position: Q1 2026 in Review

Wells Fargo held its Annovis Bio (ANVS) position steady in Q1 2026 at 14,307 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5602.

Wells Fargo first reported a position in ANVS in Q3 2020 and has held it in 23 quarters since. The position peaked at $310K in Q3 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • Wells Fargo held 14,307 shares of Annovis Bio worth $31.9K as of Q1 2026.
  • Wells Fargo left its Annovis Bio share count unchanged in Q1 2026.
  • Annovis Bio made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5602 holding.
  • Wells Fargo first reported a position in Annovis Bio in Q3 2020 and has held it in 23 quarters since.
  • Wells Fargo's Annovis Bio position peaked at $310K in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.